Clinical Trials Browser

Terminated × Hormone Refractory Prostate Cancer × Genitourinary × Clear all

NCT00313482 2012-05-11

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer

NCT00906243 2012-04-04

RNActive®-Derived Therapeutic Vaccine

Phase 1/2 Terminated

6 enrolled 5 charts

Hormone Refractory Prostate Cancer

NCT00525408 2012-03-12

HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer